Skip to main content

Table 5 The distribution of different LB manifestations suspected by the clinicians, here being retrospectively assessed as confident, doubtful, or unlikely in cases where serological testing was performed according to recommendations compared to tests taken in contradiction to recommendations

From: Serodiagnosis of Lyme borreliosis—is IgM in serum more harmful than helpful?

  Tests following guidelines (n = 183) Tests not following guidelines (n = 427)
  Confident Doubtful Unlikely No. diagnosis given Confident Doubtful Unlikely No. diagnosis given
EM 0 0 0 0 46 14 1 12
LNB 19 6 1 70 0 21 6 53
LA 10 4 0 7 0 3 13 43
BL 7 4 1 2 0 1 0 0
ACA 30 9 3 5 0 0 0 0
LC 0 0 1 3 0 0 0 0
Unspec 0 1 0 0 1 12 16 185
  1. EM, erythema migrans; LNB, Lyme neuroborreliosis; LA, Lyme arthritis; BL, borrelial lymphocytoma; ACA, acrodermatitis chronica atrophicans; LC, Lyme carditis; Unspec, unspecified suspected diagnosis